Fatigued; Fever; Headache; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of FATIGUE (Fatigued), PYREXIA (Fever) and HEADACHE (Headache) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 011J20A) for COVID-19 immunisation.     The patient's past medical history included Alcohol use (1 drink/week) on 04-Jul-2021. Concurrent medical conditions included Drug allergy (Allergy to sulfa drugs) and Migraine with aura (occasional frequency (1 every few months) has not changed.) since 01-Jan-1998. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 01-Jan-2019 to an unknown date for an unknown indication.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 08-Apr-2022. On 25-Jan-2021, the patient experienced FATIGUE (Fatigued), PYREXIA (Fever) and HEADACHE (Headache). The patient was treated with IBUPROFEN for Fever and Headache, at an unspecified dose and frequency. On 25-Jan-2021, PYREXIA (Fever) and HEADACHE (Headache) had resolved. On 26-Jan-2021, FATIGUE (Fatigued) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Jul-2021, Pregnancy test: positive (Positive) Positive.         Last menstrual period of patient was 30-JUN-2021 The patient did not have any complications or acute illnesses during the pregnancy till date and prenatal care had been established to the patient. The patient did not seek any medical care for the events. CC: This case concerns a 36 year old with relevant medical history of migraine and alcohol use, who experienced non-serious expected events of fatigue, headache  and pyrexia and unexpected event of Maternal exposure before pregnancy ,  which occurred on the same day after vaccination with the 2nd dose of mRNA-1273 (Moderna) . The re-challenge for this case is not applicable. The benefit-risk relationship of mRNA-1273 (Moderna ) is not affected by this report. This patient got pregnant approximately 5 to 6 months after vaccination with the 2nd dose of mRNA - 1273  Currently  there are no complication or illnesses noted during her present pregnancy and patient is to be followed up.   This case was linked to MOD-2021-337813 (Patient Link).; Sender's Comments: This case concerns a 36 year old with relevant medical history of migraine and alcohol use, who experienced non-serious expected events of fatigue, headache  and pyrexia and unexpected event of Maternal exposure before pregnancy ,  which occurred on the same day after vaccination with the 2nd dose of mRNA-1273 (Moderna) . The re-challenge for this case is not applicable. The benefit-risk relationship of mRNA-1273 (Moderna ) is not affected by this report. This patient got pregnant approximately 5 to 6 months after vaccination with the 2nd dose of mRNA - 1273  Currently  there are no complication or illnesses noted during her present pregnancy and patient is to be followed up.